CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.1666
4.11%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.0968
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Zepp Health Corp ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.2166
Open* 1.2366
1-Year Change* -31.54%
Day's Range* 1.1466 - 1.2466
52 wk Range 0.96-2.19
Average Volume (10 days) 91.63K
Average Volume (3 months) 1.33M
Market Cap 94.61M
P/E Ratio -100.00K
Shares Outstanding 244.15M
Revenue 412.36M
EPS -0.63
Dividend (Yield %) N/A
Beta 0.89
Next Earnings Date Mar 19, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 16, 2024 1.2166 -0.0200 -1.62% 1.2366 1.2966 1.2166
Feb 15, 2024 1.2266 -0.0700 -5.40% 1.2966 1.3266 1.2266
Feb 14, 2024 1.2966 0.0800 6.58% 1.2166 1.3066 1.1966
Feb 13, 2024 1.2366 -0.0200 -1.59% 1.2566 1.3366 1.2166
Feb 12, 2024 1.2966 0.0800 6.58% 1.2166 1.3666 1.1966
Feb 9, 2024 1.1966 0.0200 1.70% 1.1766 1.2166 1.1566
Feb 8, 2024 1.1566 -0.0300 -2.53% 1.1866 1.2166 1.1566
Feb 7, 2024 1.1766 0.0000 0.00% 1.1766 1.2466 1.1566
Feb 6, 2024 1.2166 0.0600 5.19% 1.1566 1.2266 1.1566
Feb 5, 2024 1.1366 -0.0100 -0.87% 1.1466 1.1866 1.1366
Feb 2, 2024 1.1566 0.0000 0.00% 1.1566 1.2166 1.1366
Feb 1, 2024 1.1266 -0.0300 -2.59% 1.1566 1.2066 1.1066
Jan 31, 2024 1.1766 0.0100 0.86% 1.1666 1.1966 1.1466
Jan 30, 2024 1.1966 -0.1000 -7.71% 1.2966 1.2966 1.1766
Jan 29, 2024 1.2966 -0.0700 -5.12% 1.3666 1.4366 1.2866
Jan 26, 2024 1.3666 -0.0300 -2.15% 1.3966 1.4166 1.3666
Jan 25, 2024 1.3966 -0.0700 -4.77% 1.4666 1.5166 1.3966
Jan 24, 2024 1.4466 -0.0200 -1.36% 1.4666 1.5466 1.4366
Jan 23, 2024 1.4366 -0.0700 -4.65% 1.5066 1.5866 1.4366
Jan 22, 2024 1.4366 -0.0700 -4.65% 1.5066 1.5566 1.4366

Zepp Health Events

Time (UTC) Country Event
Tuesday, March 19, 2024

Time (UTC)

12:30

Country

US

Event

Q4 2023 Zepp Health Corp Earnings Release
Q4 2023 Zepp Health Corp Earnings Release

Forecast

-

Previous

-
Tuesday, May 21, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Zepp Health Corp Earnings Release
Q1 2024 Zepp Health Corp Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 4142.86 6250.11 6433.36 5812.25 3645.33
Revenue 4142.86 6250.11 6433.36 5812.25 3645.33
Cost of Revenue, Total 3339.75 4944.47 5100.7 4344.51 2705.89
Gross Profit 803.116 1305.64 1332.67 1467.74 939.45
Total Operating Expense 4566.96 6156.17 6202.65 5208.37 3287.21
Selling/General/Admin. Expenses, Total 696.236 696.619 620.46 430.437 310.511
Research & Development 517.122 515.081 538.009 430.822 263.22
Operating Income -424.1 93.942 230.718 603.884 358.129
Interest Income (Expense), Net Non-Operating 7.747 -14.691 58.443 35.3 19.716
Other, Net 43.82 27.418 -23.552 13.186 8.768
Net Income Before Taxes -372.533 106.669 265.609 652.37 386.613
Net Income After Taxes -306.658 95.924 234.455 574.483 334.577
Equity In Affiliates 17.657 41.028 -4.749 -1.112 1.743
Net Income Before Extra. Items -288.308 137.803 228.753 575.196 340.046
Net Income -288.308 137.803 228.753 575.196 340.046
Total Adjustments to Net Income -2.45 -226.556
Income Available to Common Excl. Extra. Items -288.308 137.803 228.753 572.746 113.49
Income Available to Common Incl. Extra. Items -288.308 137.803 228.753 572.746 113.49
Diluted Net Income -288.308 137.803 228.753 572.746 113.49
Diluted Weighted Average Shares 246.283 264.369 260.352 255.959 225.035
Diluted EPS Excluding Extraordinary Items -1.17064 0.52125 0.87863 2.23765 0.50432
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -1.13406 0.52125 0.687 2.24659 0.53351
Minority Interest 0.693 0.851 -0.953 1.825 3.726
Total Extraordinary Items
Unusual Expense (Income) 13.858 0 -56.522 2.6 7.59
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 648.343 645.183 1071.73 1205.79 1108.29
Revenue 648.343 645.183 1071.73 1205.79 1108.29
Cost of Revenue, Total 505.801 542.338 849.885 975.106 909.945
Gross Profit 142.542 102.845 221.846 230.687 198.343
Total Operating Expense 720.716 796.091 1156.54 1279.05 1218.89
Selling/General/Admin. Expenses, Total 125.622 135.879 178.456 176.565 179.949
Research & Development 89.293 117.874 114.341 127.382 128.991
Operating Income -72.373 -150.908 -84.809 -73.26 -110.597
Interest Income (Expense), Net Non-Operating -2.579 -5.824 7.786 -19.241 -23.373
Other, Net -0.783 -1.985 -0.514 38.269 2.32
Net Income Before Taxes -75.735 -158.717 -77.537 -54.232 -131.65
Net Income After Taxes -64.123 -133.983 -75.033 -20.626 -118.632
Minority Interest 0.185 0.194 0.195 0.127 0.237
Equity In Affiliates -6.003 -2.931 -0.71 3.409 11.45
Net Income Before Extra. Items -69.941 -136.72 -75.548 -17.09 -106.945
Net Income -69.941 -136.72 -75.548 -17.09 -106.945
Income Available to Common Excl. Extra. Items -69.941 -136.72 -75.548 -17.09 -106.945
Income Available to Common Incl. Extra. Items -69.941 -136.72 -75.548 -17.09 -106.945
Diluted Net Income -69.941 -136.72 -75.548 -17.09 -106.945
Diluted Weighted Average Shares 243.551 245.134 244.846 245.117 245.703
Diluted EPS Excluding Extraordinary Items -0.28717 -0.55774 -0.30855 -0.06972 -0.43526
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.28717 -0.55774 -0.27176 -0.06972 -0.43526
Unusual Expense (Income) 13.858
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 2958.55 3930.95 4827.87 4392.45 2857.46
Cash and Short Term Investments 920.948 1492.85 2296.78 1820.3 1589.25
Cash & Equivalents 886.632 1473.5 2278.35 1803.12 1538.77
Short Term Investments 34.316 19.351 18.43 17.187 50.482
Total Receivables, Net 870.316 1087.93 1280 1663.96 757.474
Accounts Receivable - Trade, Net 820.717 832.698 1158.25 1610.11 715.324
Total Inventory 1021.92 1249.33 1217.54 893.806 484.622
Prepaid Expenses 55.44 58.994 26.737 11.724 11.623
Other Current Assets, Total 89.921 41.856 6.816 2.661 14.484
Total Assets 5267.64 6085.5 5903.72 5174.74 3258.48
Property/Plant/Equipment, Total - Net 166.178 242.308 275.784 173.032 40.042
Property/Plant/Equipment, Total - Gross 278.416 313.14 312.171 194.47 52.071
Accumulated Depreciation, Total -112.238 -70.832 -36.387 -21.438 -12.029
Goodwill, Net 66.081 61.055 62.515 5.93 5.93
Intangibles, Net 123.3 135.582 145.213 85.753 63.722
Long Term Investments 1686.63 1552.59 443.986 406.099 208.949
Other Long Term Assets, Total 260.575 163.012 148.355 111.477 82.382
Total Current Liabilities 1668.67 2152.13 2789.67 2481.8 1387.69
Accounts Payable 497.563 1367.43 1962.52 2014.72 1074.8
Accrued Expenses 92.646 139.701 134.678 256.077 154.303
Notes Payable/Short Term Debt 968.438 461.795 504.671 2.184 38.936
Other Current Liabilities, Total 110.021 183.207 187.805 208.819 119.652
Total Liabilities 2595.12 3165.15 3173.46 2673.99 1447.57
Total Long Term Debt 684.21 726.851 60 0 0
Deferred Income Tax 35.552 26.909 22.374 5.399 4.962
Minority Interest 12.399 13.092 0 -3.162 -1.337
Other Liabilities, Total 194.292 246.17 301.413 189.956 56.249
Total Equity 2672.52 2920.35 2730.26 2500.75 1810.92
Preferred Stock - Non Redeemable, Net
Common Stock 0.162 0.159 0.157 0.155 0.151
Additional Paid-In Capital 1690.88 1641.54 1552.11 1478.9 1373.58
Retained Earnings (Accumulated Deficit) 942.848 1271.17 1133.37 910.612 340.046
Other Equity, Total 105.796 29.271 44.624 111.081 97.141
Total Liabilities & Shareholders’ Equity 5267.64 6085.5 5903.72 5174.74 3258.48
Total Common Shares Outstanding 251.201 251.201 250.145 247.52 241.68
Redeemable Preferred Stock 0
Long Term Debt 684.21 726.851 60
Treasury Stock - Common -67.163 -21.798
Note Receivable - Long Term 6.333
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 2504.32 2612.16 2595.02 2958.55 3456.28
Cash and Short Term Investments 952.849 1044.8 996.258 920.948 983.519
Cash & Equivalents 928.22 1013.92 961.478 886.632 945.509
Short Term Investments 24.629 30.882 34.78 34.316 38.01
Total Receivables, Net 578.93 643.912 626.966 820.717 856.889
Accounts Receivable - Trade, Net 578.93 643.912 626.966 820.717 856.889
Total Inventory 786.962 742.571 799.933 1021.92 1375.12
Prepaid Expenses 127.787 125.831 126.873 108.252 175.524
Other Current Assets, Total 57.794 55.04 44.988 86.708 65.231
Total Assets 4833.05 4929.89 4898.93 5267.64 5821.07
Property/Plant/Equipment, Total - Net 111.63 117.361 142.142 166.178 189.889
Goodwill, Net 69.902 69.474 65.797 66.081 68.153
Intangibles, Net 104.862 108.971 119.038 123.3 128.873
Long Term Investments 1696.28 1694.78 1681.38 1686.63 1713.39
Other Long Term Assets, Total 339.223 320.404 289.205 260.575 264.487
Total Current Liabilities 1222.61 1358.5 1204.01 1668.67 2096.13
Accounts Payable 479.777 472.824 364.18 497.563 869.973
Accrued Expenses 152.566 150.396 157.007 197.819 210.928
Notes Payable/Short Term Debt 566.37 716.457 669.542 968.438 971.228
Other Current Liabilities, Total 23.893 18.821 13.279 4.848 43.998
Total Liabilities 2309.02 2424.33 2354.31 2595.12 3050.16
Total Long Term Debt 861.412 844.699 923.982 684.21 688.063
Long Term Debt 861.412 844.699 923.982 684.21 688.063
Deferred Income Tax 33.664 33.863 34.658 35.552 38.928
Minority Interest 11.827 12.02 12.205 12.399 12.594
Other Liabilities, Total 179.512 175.249 179.458 194.292 214.45
Total Equity 2524.02 2505.56 2544.62 2672.52 2770.91
Common Stock 0.164 0.164 0.163 0.162 0.159
Additional Paid-In Capital 1738.54 1725.57 1714.88 1690.88 1675.69
Retained Earnings (Accumulated Deficit) 739.162 736.187 806.128 942.848 1018.4
Other Equity, Total 127.565 120.549 96.252 105.796 135.584
Total Liabilities & Shareholders’ Equity 4833.05 4929.89 4898.93 5267.64 5821.07
Total Common Shares Outstanding 244.152 244.152 244.152 251.201 251.201
Treasury Stock - Common -81.408 -76.905 -72.803 -67.163 -58.918
Note Receivable - Long Term 6.832 6.746 6.348 6.333
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -289.001 136.952 229.706 573.371 336.32
Cash From Operating Activities -787.643 -232.435 157.302 427.999 707.605
Cash From Operating Activities 58.618 51.884 27.129 9.409 5.773
Deferred Taxes -65.22 -18.694 -10.442 -27.8 -32.895
Non-Cash Items 71.759 122.289 120.876 114.907 138.256
Cash Taxes Paid 3.443 74.377 82.406 91.732 52.063
Changes in Working Capital -563.799 -524.866 -209.967 -249.694 259.708
Cash From Investing Activities -42.258 -1069.29 -206.88 -112.703 -324.841
Capital Expenditures -9.92 -53.082 -84.774 -46.121 -69.153
Other Investing Cash Flow Items, Total -32.338 -1016.21 -122.106 -66.582 -255.688
Cash From Financing Activities 289.198 551.077 564.671 25.609 639.17
Issuance (Retirement) of Stock, Net -53.216 -8.298 0.933 652.391
Issuance (Retirement) of Debt, Net 421.624 520.18 564.671 -20 -13.221
Foreign Exchange Effects 4.504 -15.564 -43.334 11.274 60.357
Net Change in Cash -536.199 -766.211 471.759 352.179 1082.29
Amortization 7.806 0.443
Cash Interest Paid 55.847 47.132 14.858 0.286 1.31
Financing Cash Flow Items -39.195 39.195 44.676
Total Cash Dividends Paid -40.015
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Allspring Global Investments, LLC Investment Advisor/Hedge Fund 16.1779 5134210 0 2023-09-30 LOW
Fidelity International Investment Advisor 5.7593 1827770 -170313 2023-06-30 LOW
FIL Investment Management (Hong Kong) Limited Investment Advisor 3.8846 1232834 -37407 2023-06-30 HIGH
Huang (Wang) Individual Investor 3.3559 1065019 0 2022-12-31
Florida State Board of Administration Pension Fund 1.4779 469042 -20500 2022-09-30 LOW
SEI Investments Management Corporation Investment Advisor/Hedge Fund 1.1309 358906 0 2023-06-30 LOW
Axxion S.A. Investment Advisor 0.4726 150000 50000 2023-09-30 LOW
Renaissance Technologies LLC Hedge Fund 0.3094 98200 -1400 2023-06-30 HIGH
Citadel Advisors LLC Hedge Fund 0.2891 91762 30192 2023-06-30 LOW
Susquehanna International Group, LLP Investment Advisor 0.0984 31239 -8855 2023-06-30 MED
Mandatum Asset Management Ltd Investment Advisor 0.0851 27000 0 2023-09-30 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.0772 24510 -50153 2023-06-30 LOW
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.0766 24307 -3647 2023-06-30 MED
LPL Financial LLC Investment Advisor 0.0687 21803 -1350 2023-06-30 LOW
Millennium Management LLC Hedge Fund 0.0536 16997 -6656 2023-06-30 HIGH
Hansen & Heinrich Aktiengesellschaft Investment Advisor 0.0473 15000 0 2022-04-30 MED
Morgan Stanley & Co. LLC Research Firm 0.0472 14968 -6616 2023-06-30 MED
Gesinter S.G.I.I.C., S.A. Investment Advisor 0.0315 9999 -11583 2023-06-30 HIGH
Osaic Holdings, Inc. Investment Advisor 0.0115 3640 -145 2023-06-30 LOW
Rhumbline Advisers Ltd. Partnership Investment Advisor 0.0107 3390 3390 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Zepp Health Company profile

About Zepp Health Corp - ADR

Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. It has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. It is engaged in developing smart wearable technology. It designs and develops biometric and activity data-driven fitness and smart watches. It markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. It also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Zepp Health Corp - ADR revenues decreased 3% to RMB6.25B. Net income decreased 40% to RMB137.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Interest income decrease of 64% to RMB16.7M (income), Gain from fair value change of long-term decrease from RMB12.3M (income) to RMB0K.

Industry: Phones & Handheld Devices (NEC)

Building B2, Zhong'an Chuanggu Technology Park, No.900 Wangjiang West Rd
HEFEI
ANHUI 230088
CN

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Oil - Crude

77.17 Price
-1.340% 1D Chg, %
Long position overnight fee 0.0081%
Short position overnight fee -0.0300%
Overnight fee time 22:00 (UTC)
Spread 0.030

XRP/USD

0.57 Price
-0.040% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

17,539.60 Price
-1.040% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

52,153.00 Price
+0.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading